Hims & Hers Health (HIMS) Competitors

$25.24 +1.39 (+5.82%)

Closing price 03:59 PM Eastern

Extended Trading

$25.23 -0.01 (-0.02%)

As of 06:56 PM Eastern

HIMS vs. GH, FMS, BTSG, CELC, and PACS

Should you buy Hims & Hers Health stock or one of its competitors? MarketBeat compares Hims & Hers Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hims & Hers Health include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Hims & Hers Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Guardant Health has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.43, suggesting that its stock price is 143% more volatile than the broader market.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Hims & Hers Health had 12 more articles in the media than Guardant Health. MarketBeat recorded 31 mentions for Hims & Hers Health and 19 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.31 beat Guardant Health's score of 0.17 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	7 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Hims & Hers Health	12 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Hims & Hers Health	-0.56%	6.10%	1.52%

Guardant Health currently has a consensus target price of $129.79, indicating a potential upside of 1.79%. Hims & Hers Health has a consensus target price of $28.70, indicating a potential upside of 13.72%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$1.08B	15.65	-$416.28M	-$3.39	N/A
Hims & Hers Health	$2.37B	2.46	$128.37M	-$0.09	N/A

Summary

Hims & Hers Health beats Guardant Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Hims & Hers Health's net margin of -0.56%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hims & Hers Health currently has a consensus target price of $28.70, indicating a potential upside of 13.72%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 29.78%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	2.46	$128.37M	-$0.09	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.36

In the previous week, Hims & Hers Health had 25 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 31 mentions for Hims & Hers Health and 6 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.79 beat Hims & Hers Health's score of 0.31 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Fresenius Medical Care AG & Co. KGaA beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 31 mentions for Hims & Hers Health and 15 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.84 beat Hims & Hers Health's score of 0.31 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
BrightSpring Health Services	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 13.72%. BrightSpring Health Services has a consensus target price of $57.00, indicating a potential downside of 5.86%. Given Hims & Hers Health's higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12

BrightSpring Health Services has a net margin of 2.27% compared to Hims & Hers Health's net margin of -0.56%. BrightSpring Health Services' return on equity of 14.63% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
BrightSpring Health Services	2.27%	14.63%	4.41%

Hims & Hers Health has a beta of 2.43, suggesting that its share price is 143% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	2.46	$128.37M	-$0.09	N/A
BrightSpring Health Services	$12.91B	0.91	$190.67M	$1.41	42.94

Summary

BrightSpring Health Services beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 31 more articles in the media than Celcuity. MarketBeat recorded 31 mentions for Hims & Hers Health and 0 mentions for Celcuity. Hims & Hers Health's average media sentiment score of 0.31 beat Celcuity's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Celcuity	Neutral
Hims & Hers Health	Neutral

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Hims & Hers Health	$2.37B	2.46	$128.37M	-$0.09	N/A

Celcuity has a beta of 0.09, indicating that its stock price is 91% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market.

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Hims & Hers Health	-0.56%	6.10%	1.52%

Celcuity currently has a consensus target price of $149.30, suggesting a potential upside of 11.44%. Hims & Hers Health has a consensus target price of $28.70, suggesting a potential upside of 13.72%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Summary

Hims & Hers Health beats Celcuity on 10 of the 15 factors compared between the two stocks.

How does Hims & Hers Health compare to PACS Group?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

Hims & Hers Health currently has a consensus price target of $28.70, suggesting a potential upside of 13.72%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 22.03%. Given PACS Group's stronger consensus rating and higher possible upside, analysts plainly believe PACS Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, Hims & Hers Health had 27 more articles in the media than PACS Group. MarketBeat recorded 31 mentions for Hims & Hers Health and 4 mentions for PACS Group. PACS Group's average media sentiment score of 0.97 beat Hims & Hers Health's score of 0.31 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
PACS Group	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
PACS Group	4.49%	26.47%	4.36%

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	2.46	$128.37M	-$0.09	N/A
PACS Group	$5.43B	1.15	$191.54M	$1.56	25.21

Hims & Hers Health has a beta of 2.43, suggesting that its share price is 143% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, suggesting that its share price is 103% less volatile than the broader market.

Summary

PACS Group beats Hims & Hers Health on 12 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$5.84B	$1.45B	$6.37B	$23.16B
Dividend Yield	N/A	N/A	2.76%	4.09%
P/E Ratio	-280.41	64.39	20.95	30.93
Price / Sales	2.46	5.75	513.04	153.95
Price / Cash	28.38	22.72	43.49	25.06
Price / Book	13.08	7.33	10.39	4.78
Net Income	$128.37M	-$54.76M	$3.56B	$1.07B
7 Day Performance	9.45%	2.40%	2.96%	1.86%
1 Month Performance	-13.91%	8.56%	2.40%	1.43%
1 Year Performance	-52.73%	-0.92%	36.13%	26.97%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	3.5886 of 5 stars	$25.24 +5.8%	$28.70 +13.7%	-56.7%	$5.84B	$2.37B	N/A	2,442	Trending News Analyst Forecast Insider Trade Gap Up
GH Guardant Health	1.8686 of 5 stars	$108.09 +10.1%	$129.42 +19.7%	+215.4%	$14.34B	$982.02M	N/A	2,506	Analyst Forecast Insider Trade Gap Up
FMS Fresenius Medical Care AG & Co. KGaA	4.8259 of 5 stars	$22.18 +0.3%	$28.00 +26.3%	-25.5%	$12.38B	$19.36B	11.67	1,488	Positive News
BTSG BrightSpring Health Services	3.6206 of 5 stars	$58.42 +3.0%	$56.29 -3.7%	+159.7%	$11.32B	$12.91B	41.39	23,500
CELC Celcuity	1.7187 of 5 stars	$136.68 +4.4%	$149.30 +9.2%	+1,186.0%	$6.64B	N/A	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 5/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, FMS, BTSG, CELC, and PACS

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to Celcuity?

Summary

How does Hims & Hers Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, FMS, BTSG, CELC, and PACS

How does Hims & Hers Health compare to Guardant Health?

Which has more volatility & risk, GH or HIMS?

Do institutionals & insiders have more ownership in GH or HIMS?

Does the media favor GH or HIMS?

Is GH or HIMS more profitable?

Do analysts prefer GH or HIMS?

Which has preferable valuation and earnings, GH or HIMS?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Is HIMS or FMS more profitable?

Which has more risk & volatility, HIMS or FMS?

Do insiders and institutionals believe in HIMS or FMS?

Do analysts rate HIMS or FMS?

Which has higher valuation & earnings, HIMS or FMS?

Does the media refer more to HIMS or FMS?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Do institutionals & insiders have more ownership in HIMS or BTSG?

Does the media favor HIMS or BTSG?

Do analysts prefer HIMS or BTSG?

Is HIMS or BTSG more profitable?

Which has more volatility and risk, HIMS or BTSG?

Which has higher earnings and valuation, HIMS or BTSG?

Summary

How does Hims & Hers Health compare to Celcuity?

Do insiders & institutionals hold more shares of CELC or HIMS?

Does the media favor CELC or HIMS?

Which has stronger valuation and earnings, CELC or HIMS?

Which has more risk & volatility, CELC or HIMS?

Is CELC or HIMS more profitable?

Do analysts prefer CELC or HIMS?

Summary

How does Hims & Hers Health compare to PACS Group?

Do analysts rate HIMS or PACS?

Does the media refer more to HIMS or PACS?

Is HIMS or PACS more profitable?

Do insiders and institutionals believe in HIMS or PACS?

Which has preferable valuation & earnings, HIMS or PACS?

Which has more volatility & risk, HIMS or PACS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools